Skip to main content
Clinical Trials/NCT01844388
NCT01844388
Completed
Phase 3

A Study to Compare a New Eye Drop Formulation With Refresh Contacts®

Allergan0 sites365 target enrollmentMay 29, 2013

Overview

Phase
Phase 3
Intervention
carboxymethylcellulose based eye drop formula
Conditions
Contact Lens Lubrication
Sponsor
Allergan
Enrollment
365
Primary Endpoint
Percentage of Participants With Contact Lens Distance Visual Acuity Change From Baseline
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study will compare the safety and efficacy of a new carboxymethylcellulose based eye drop formula to Refresh Contacts® for lubricating and rewetting contact lenses.

Registry
clinicaltrials.gov
Start Date
May 29, 2013
End Date
December 2, 2013
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Allergan
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adapted contact wearer with daily usage of at least 6 hours a day, 5 days a week.

Exclusion Criteria

  • Wearing monovision lenses
  • Have had refractive surgery within the previous 12 months
  • Have infection of the eye, eyelids or eye structures.

Arms & Interventions

Carboxymethylcellulose Based Eye Drop Formula

1-2 drops of carboxymethylcellulose based eye drop formula in each eye, a minimum of 4 times a day for 90 days. One of the 4 times a day may be to prepare the contact lens for insertion.

Intervention: carboxymethylcellulose based eye drop formula

REFRESH CONTACTS®

1-2 drops carboxymethylcellulose sodium based eye drop solution (REFRESH CONTACTS®) in each eye, a minimum of 4 times a day for 90 days. One of the 4 times a day may be to prepare the contact lens for insertion.

Intervention: carboxymethylcellulose sodium based eye drop solution

Outcomes

Primary Outcomes

Percentage of Participants With Contact Lens Distance Visual Acuity Change From Baseline

Time Frame: Baseline, Day 90

Contact lens distance visual acuity was measured for each eye using the LogMAR visual acuity eye chart. The worse eye at Baseline was used for analysis. A change of 0.1 on the LogMAR scale was equivalent to a 1 line change in visual acuity. The following categories are reported: Better=an increase in 2 or more lines, No Change=a change of +/- 1 line, and Worse=a decrease of 2 lines or more.

Similar Trials